(Q72005574)

English

Screening experience and baseline characteristics in the West of Scotland Coronary Prevention Study. The WOSCOPS Study Group. West of Scotland Coronary Prevention Study

scientific article published on 01 September 1995

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7653449%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

Screening experience and baseline characteristics in the West of Scotland Coronary Prevention Study. The WOSCOPS Study Group. West of Scotland Coronary Prevention Study (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7653449%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

language of work or name

0 references

publication date

1 September 1995

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7653449%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

American Journal of Cardiology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7653449%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

76

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7653449%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7653449%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

485-491

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7653449%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

Effects of pravastatin in patients with serum total cholesterol levels from 5.2 to 7.8 mmol/liter (200 to 300 mg/dl) plus two additional atherosclerotic risk factors. The Pravastatin Multinational Study Group for Cardiac Risk Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980135-0

7 January 2021

Pravastatin experience in elderly and non-elderly patients

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980135-0

7 January 2021

A co-operative trial in the primary prevention of ischaemic heart disease using clofibrate. Report from the Committee of Principal Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980135-0

7 January 2021

The coronary primary prevention trial: design and implementation: the Lipid Research Clinics Program

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980135-0

7 January 2021

The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980135-0

7 January 2021

The Helsinki Heart Study: basic design and randomization procedure

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980135-0

7 January 2021

Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980135-0

7 January 2021

A coronary primary prevention study of Scottish men aged 45-64 years: trial design. The West of Scotland Coronary Prevention Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980135-0

7 January 2021

Concomitants of excess coronary deaths--major risk factor and lifestyle findings from 10,359 men and women in the Scottish Heart Health Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980135-0

7 January 2021

Serum cholesterol levels and cancer mortality in 361,662 men screened for the Multiple Risk Factor Intervention Trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980135-0

7 January 2021

Plasma cholesterol, coronary heart disease, and cancer in the Renfrew and Paisley survey

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980135-0

7 January 2021

Lowering cholesterol concentrations and mortality: a quantitative review of primary prevention trials

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980135-0

7 January 2021

Health policy on blood cholesterol. Time to change directions

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980135-0

7 January 2021

Assessing possible hazards of reducing serum cholesterol

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980135-0

7 January 2021

Identifiers

10.1016/S0002-9149(99)80135-0

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7653449%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7653449%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q72005574&oldid=1688237214"